Nav: Home

Lower risk of heart disease and stroke in people with Type 2 diabetes taking atorvastatin

June 06, 2004

A daily dose of the cholesterol-lowering drug atorvastatin (Lipitor) can reduce the risk of a first major cardiovascular event (heart attack or stroke) by more than one third in people with Type 2 diabetes, according to the results of the CARDS study presented today at the American Diabetes Association's 64th Scientific Sessions in Orlando, USA.

CARDS (Collaborative AtoRvastatin Diabetes Study) was sponsored by the charity Diabetes UK, the Department of Health and Pfizer. The study found that a daily 10mg dose of atorvastatin reduced the risk of a major cardiovascular event by 37%; for instance, serious heart problems were reduced by more than one third (36%) and strokes by almost half (48%). Importantly, these benefits were observed even amongst patients whose LDL-cholesterol levels were already quite low before treatment.

Professor John Betteridge, CARDS co-principal investigator and Professor of Endocrinology and Metabolism at UCL, says: "This exciting study has very important implications for the cardiovascular health of people with Type 2 diabetes. For all patients with Type 2 diabetes consideration should now be given to whether they warrant statin therapy. What this study shows is in this case, atorvastatin treatment is safe and highly effective at reducing the risk of cardiovascular disease."

The trial, co-ordinated at UCL, was carried out in 132 centres in the UK and Ireland and involved 2,838 people with Type 2 diabetes, each taking a daily dose of 10mg of atorvastatin or placebo. Participants entered CARDS with no previous history of heart disease or stroke, but with some cardiovascular risk factors other than diabetes and with relatively low levels of cholesterol.

The study was due to run until 2005 but was stopped in June 2003 when interim results showed a significant reduction in the risk of heart attacks, strokes or the need for cardiovascular surgery in participants taking atorvastatin.

There are 1.4 million people in the UK diagnosed with diabetes. People with Type 2 diabetes (the most common form of the disease) are at significantly increased risk of developing cardiovascular disease compared to people without diabetes.

CARDS is the first clinical trial specifically designed to investigate the effectiveness of cholesterol lowering with a statin in people with Type 2 diabetes who have no previous history of heart disease or stroke.

Paper describing the design of CARDS available at: http://www.blackwell-synergy.com/

Baseline data - the characteristics of patients entering the study - will be published in the journal Diabetic Medicine in July.

The main results of the study will be published later this year.
-end-
See the CARDS Website www.cardstrial.org for further information.

CARDS Executive Committee
Professor John Betteridge,* University College London
Professor Helen Colhoun,* CARDS Co-ordinating Centre, University College London
Professor Paul Durrington,* CARDS Central Laboratory, University of Manchester
Professor John Fuller,* CARDS Co-ordinating Centre, University College London
Professor Graham Hitman,* Barts and The London, Queen Mary's School of Medicine & Dentistry
Ms Dot Lambert, Department of Health - Study Sponsor
Dr Moira Murphy, Diabetes UK - Study Sponsor
Dr Andrew Neil,* University of Oxford Dr Craig Stevenson, Pfizer UK Ltd - Study Sponsor
* Co-principal investigator

For more information, please contact:
Jenny Gimpel (University College London Press Office) on tel 44-207-679-9739, Mobile 44-799-067-5947

University College London

Related Diabetes Articles:

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
Reverse your diabetes -- and you can stay diabetes-free long-term
A new study from Newcastle University, UK, has shown that people who reverse their diabetes and then keep their weight down remain free of diabetes.
More Diabetes News and Diabetes Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Risk
Why do we revere risk-takers, even when their actions terrify us? Why are some better at taking risks than others? This hour, TED speakers explore the alluring, dangerous, and calculated sides of risk. Guests include professional rock climber Alex Honnold, economist Mariana Mazzucato, psychology researcher Kashfia Rahman, structural engineer and bridge designer Ian Firth, and risk intelligence expert Dylan Evans.
Now Playing: Science for the People

#541 Wayfinding
These days when we want to know where we are or how to get where we want to go, most of us will pull out a smart phone with a built-in GPS and map app. Some of us old timers might still use an old school paper map from time to time. But we didn't always used to lean so heavily on maps and technology, and in some remote places of the world some people still navigate and wayfind their way without the aid of these tools... and in some cases do better without them. This week, host Rachelle Saunders...
Now Playing: Radiolab

Dolly Parton's America: Neon Moss
Today on Radiolab, we're bringing you the fourth episode of Jad's special series, Dolly Parton's America. In this episode, Jad goes back up the mountain to visit Dolly's actual Tennessee mountain home, where she tells stories about her first trips out of the holler. Back on the mountaintop, standing under the rain by the Little Pigeon River, the trip triggers memories of Jad's first visit to his father's childhood home, and opens the gateway to dizzying stories of music and migration. Support Radiolab today at Radiolab.org/donate.